CXCR2-expressing MDSCs are also recruited into the colonic mucosa of AOM/DSS-treated mice, which resulted in inhibition of CD8+ T cell effector functions, thereby accelerating tumor growth [158]. The gene discussed is CD8A; the disease is neoplasm.